Crossmark

Ultraprotective versus apneic ventilation in acute respiratory distress syndrome patients with extracorporeal membrane oxygenation: a physiological study

Crossref DOI link: https://doi.org/10.1186/s40560-022-00604-9

Published Online: 2022-03-07

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Graf, Peter T.

Boesing, Christoph

Brumm, Isabel

Biehler, Jonas

Müller, Kei Wieland

Thiel, Manfred

Pelosi, Paolo

Rocco, Patricia R. M.

Luecke, Thomas

Krebs, Joerg https://orcid.org/0000-0003-3037-0144
Clinical Trials ^BETA

Clinical trials referenced in this document:

drks00013967 at German Clinical Trials Register

Documents that mention this clinical trial

Ultraprotective versus apneic ventilation in acute respiratory distress syndrome patients with extracorporeal membrane oxygenation: a physiological study
https://doi.org/10.1186/s40560-022-00604-9
Funding

Funding for this research was provided by:

Medizinische Fakultät Mannheim der Universität Heidelberg
License Information

Text and Data Mining valid from 2022-03-07

Version of Record valid from 2022-03-07
More Information

Article History

Received: 28 September 2021

Accepted: 27 February 2022

First Online: 7 March 2022

Declarations

:

: The study was approved (registration number 2012-316 N-MA) by the local ethics committee (Medizinische Ethikkommission II, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim), registered at the German Clinical Trials Register (DRKS00013967) and written informed consent of each patient or next of kin was acquired.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below